Phase I-II trial of ONYX-015 in combination with MAP chemotherapy in patients with advanced sarcomas (Q45880512)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Phase I-II trial of ONYX-015 in combination with MAP chemotherapy in patients with advanced sarcomas
scientific article

    Statements

    Phase I-II trial of ONYX-015 in combination with MAP chemotherapy in patients with advanced sarcomas (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit